Literature DB >> 22214208

Regulatory T cell frequencies do not correlate with breadth or magnitude of HIV-1-specific T cell responses.

Mathieu Angin, Hendrik Streeck, Fang Wen, Melanie King, Florencia Pereyra, Marcus Altfeld, Bruce D Walker, Marylyn M Addo.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 22214208      PMCID： PMC3399566          DOI： 10.1089/AID.2011.0353

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN： 0889-2229            Impact factor:   2.205


× No keyword cloud information.
  14 in total

1.  Depletion of CD25+CD4+T cells (Tregs) enhances the HBV-specific CD8+ T cell response primed by DNA immunization.

Authors:  Yoshihiro Furuichi; Hirotake Tokuyama; Satoshi Ueha; Makoto Kurachi; Fuminori Moriyasu; Kazuhiro Kakimi
Journal:  World J Gastroenterol       Date:  2005-06-28       Impact factor: 5.742

2.  Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART.

Authors:  Hans-Jörg Epple; Christoph Loddenkemper; Desirée Kunkel; Hanno Tröger; Jochen Maul; Verena Moos; Erika Berg; Reiner Ullrich; Jörg-Dieter Schulzke; Harald Stein; Rainer Duchmann; Martin Zeitz; Thomas Schneider
Journal:  Blood       Date:  2006-05-25       Impact factor: 22.113

3.  Increased frequency of regulatory T cells accompanies increased immune activation in rectal mucosae of HIV-positive noncontrollers.

Authors:  Julia M Shaw; Peter W Hunt; J William Critchfield; Delandy H McConnell; Juan Carlos Garcia; Richard B Pollard; Ma Somsouk; Steven G Deeks; Barbara L Shacklett
Journal:  J Virol       Date:  2011-08-31       Impact factor: 5.103

4.  HIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.

Authors:  Rachel E Owen; John W Heitman; Dale F Hirschkorn; Marion C Lanteri; Hope H Biswas; Jeffrey N Martin; Melissa R Krone; Steven G Deeks; Philip J Norris
Journal:  AIDS       Date:  2010-05-15       Impact factor: 4.177

5.  Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Authors:  Florencia Pereyra; Marylyn M Addo; Daniel E Kaufmann; Yang Liu; Toshiyuki Miura; Almas Rathod; Brett Baker; Alicja Trocha; Rachel Rosenberg; Elizabeth Mackey; Peggy Ueda; Zhigang Lu; Daniel Cohen; Terri Wrin; Christos J Petropoulos; Eric S Rosenberg; Bruce D Walker
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

6.  Preservation of FoxP3+ regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4+ T-cell activation.

Authors:  Amanda J Chase; Hung-Chih Yang; Hao Zhang; Joel N Blankson; Robert F Siliciano
Journal:  J Virol       Date:  2008-06-25       Impact factor: 5.103

7.  Suppression of HIV-specific T cell activity by lymph node CD25+ regulatory T cells from HIV-infected individuals.

Authors:  Audrey Kinter; Jonathan McNally; Lindsey Riggin; Robert Jackson; Gregg Roby; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-21       Impact factor: 11.205

8.  Depletion of human regulatory T cells specifically enhances antigen-specific immune responses to cancer vaccines.

Authors:  Michael A Morse; Amy C Hobeika; Takuya Osada; Delila Serra; Donna Niedzwiecki; H Kim Lyerly; Timothy M Clay
Journal:  Blood       Date:  2008-06-02       Impact factor: 22.113

9.  Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load.

Authors:  M M Addo; X G Yu; A Rathod; D Cohen; R L Eldridge; D Strick; M N Johnston; C Corcoran; A G Wurcel; C A Fitzpatrick; M E Feeney; W R Rodriguez; N Basgoz; R Draenert; David R Stone; C Brander; P J R Goulder; E S Rosenberg; M Altfeld; B D Walker
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

10.  CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status.

Authors:  Audrey L Kinter; Margaret Hennessey; Alicia Bell; Sarah Kern; Yin Lin; Marybeth Daucher; Maria Planta; Mary McGlaughlin; Robert Jackson; Steven F Ziegler; Anthony S Fauci
Journal:  J Exp Med       Date:  2004-07-26       Impact factor: 14.307
View more
  1 in total

Review 1.  Immunologic characteristics of HIV-infected individuals who make broadly neutralizing antibodies.

Authors:  Persephone Borrow; M Anthony Moody
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.